E-Qure Corp. (EQUR) Stock
E-Qure Corp., a medical technology firm, is dedicated to the development and distribution of medical devices that utilize bioelectrical signal therapy (BST). These BST devices leverage their exclusive and patented electrical stimulation techniques to address and resolve challenging, difficult-to-heal wounds and ulcers, aiming for their full closure and recovery.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About E-Qure Corp.
E-Qure Corp., a medical technology firm, is dedicated to the development and distribution of medical devices that utilize bioelectrical signal therapy (BST). These BST devices leverage their exclusive and patented electrical stimulation techniques to address and resolve challenging, difficult-to-heal wounds and ulcers, aiming for their full closure and recovery. The company was founded in 1988 and operates from its headquarters in New York, New York.
E-Qure Corp. (EQUR) stock trades at $0.00 with a market capitalization of $6909. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of -0.02, price-to-sales of 0.00.
On profitability, E-Qure Corp. generates a return on equity (ROE) of 175.41% — well above the market average, a sign of a high-quality business, return on capital employed of 162.38%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.e-qure.com